167 related articles for article (PubMed ID: 9813248)
1. Ganglioside GM1 potentiates NGF action on axotomised medial septal cholinergic neurons.
Panni MK; Cooper JD; Sofroniew MV
Brain Res; 1998 Nov; 812(1-2):76-80. PubMed ID: 9813248
[TBL] [Abstract][Full Text] [Related]
2. Leukaemia inhibitory factor prevents loss of p75-nerve growth factor receptor immunoreactivity in medial septal neurons following fimbria-fornix lesions.
Panni MK; Atkinson J; Sofroniew MV
Neuroscience; 1999; 89(4):1113-21. PubMed ID: 10362299
[TBL] [Abstract][Full Text] [Related]
3. Axotomized septal cholinergic neurons rescued by nerve growth factor or neurotrophin-4/5 fail to express the inducible transcription factor c-Jun.
Hughes PE; Alexi T; Hefti F; Knusel B
Neuroscience; 1997 Jun; 78(4):1037-49. PubMed ID: 9174072
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons.
Cuello AC; Garofalo L; Kenigsberg RL; Maysinger D
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2056-60. PubMed ID: 2928318
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1.
Garofalo L; Ribeiro-da-Silva A; Cuello AC
Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons.
Hagg T; Fass-Holmes B; Vahlsing HL; Manthorpe M; Conner JM; Varon S
Brain Res; 1989 Dec; 505(1):29-38. PubMed ID: 2558781
[TBL] [Abstract][Full Text] [Related]
7. Axotomy-induced c-JUN expression in young medial septal neurons is regulated by nerve growth factor.
Haas CA; Bach A; Heimrich B; Linke R; Otten U; Frotscher M
Neuroscience; 1998 Dec; 87(4):831-44. PubMed ID: 9759971
[TBL] [Abstract][Full Text] [Related]
8. Recovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression.
Naumann T; Straube A; Frotscher M
Eur J Neurosci; 1997 Jul; 9(7):1340-9. PubMed ID: 9240391
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection.
Morse JK; Wiegand SJ; Anderson K; You Y; Cai N; Carnahan J; Miller J; DiStefano PS; Altar CA; Lindsay RM
J Neurosci; 1993 Oct; 13(10):4146-56. PubMed ID: 8080477
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor maintains choline acetyltransferase expression in vivo.
Cheema SS; Arumugam D; Murray SS; Bartlett PF
Neuroreport; 1998 Feb; 9(3):363-6. PubMed ID: 9512372
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
Garofalo L; Cuello AC
Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin-4/5 maintains the cholinergic phenotype of axotomized septal neurons.
Alderson RF; Wiegand SJ; Anderson KD; Cai N; Cho JY; Lindsay RM; Altar CA
Eur J Neurosci; 1996 Feb; 8(2):282-90. PubMed ID: 8714699
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives.
Fusco M; Vantini G; Schiavo N; Zanotti A; Zanoni R; Facci L; Skaper SD
Ann N Y Acad Sci; 1993 Sep; 695():314-7. PubMed ID: 8239303
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
Garofalo L; Cuello AC
J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
[TBL] [Abstract][Full Text] [Related]
15. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment.
Montero CN; Hefti F
J Neurosci; 1988 Aug; 8(8):2986-99. PubMed ID: 2842469
[TBL] [Abstract][Full Text] [Related]
16. GM1 ganglioside enhances cholinergic parameters in the brain of senescent rats.
Hadjiconstantinou M; Karadsheh NS; Rattan AK; Tejwani GA; Fitkin JG; Neff NH
Neuroscience; 1992; 46(3):681-6. PubMed ID: 1545916
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.
Koliatsos VE; Applegate MD; Knüsel B; Junard EO; Burton LE; Mobley WC; Hefti FF; Price DL
Exp Neurol; 1991 May; 112(2):161-73. PubMed ID: 2037030
[TBL] [Abstract][Full Text] [Related]
18. Effects of nerve growth factor and GM1 ganglioside on the number and size of cholinergic neurons in rats with unilateral lesion of the nucleus basalis.
Casamenti F; Di Patre PL; Milan F; Petrelli L; Pepeu G
Neurosci Lett; 1989 Aug; 103(1):87-91. PubMed ID: 2779858
[TBL] [Abstract][Full Text] [Related]
19. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
Casamenti F; Milan F; Pepeu G
Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
[TBL] [Abstract][Full Text] [Related]
20. Primate nucleus basalis of Meynert p75NGFR-containing cholinergic neurons are protected from retrograde degeneration by the ganglioside GM1.
Pioro EP; Maysinger D; Ervin FR; Desypris G; Cuello AC
Neuroscience; 1993 Mar; 53(1):49-56. PubMed ID: 8469311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
